PROSIDION LIMITED SCIENTIFIC ADVISORY BOARD AND CONSULTING AGREEMENTBoard and Consulting Agreement • February 13th, 2006 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • England and Wales
This Scientific Advisory Board and Consulting Agreement (this “Agreement”) is made and entered into as of February 10, 2006 (“the “Effective Date”) by and between Prosidion Limited, a company registered in England and Wales under registered number 4600121 with its registered office at Watlington Road, Oxford, UK OX4 6LT (the “Company”) and Dr Daryl Granner, Professor, an individual with an address of 707 Light Hall, Vanderbilt University Medical Centre, Nashville, Tennessee 37232, USA (“Consultant”).
BOARD AND CONSULTING AGREEMENT BETWEEN ROB GELLER, CONSULTANT AND THE ICOM GROUP, INC.Board and Consulting Agreement • August 2nd, 2002 • Pelion Systems Inc • Services-prepackaged software
Rob Geller will work with The ICOM Group as both a member of the board of directors and as a consultant to the Company. As compensation for the standard board duties, Rob Geller will receive a non-statutory stock option with early exercise provisions under the Company’s stock option plan in the amount of 100,000 shares at cents per share vested monthly over a 2-year period. For this, Rob Geller will provide the expected duties as a member of the board of directors. These duties include attending board meetings which are expected to be as frequent as every month moving to at least once per quarter based on the needs of the Company. Also included is preparation for board meetings and phone conversations and email communication on an ongoing basis.
RECITALSBoard and Consulting Agreement • March 8th, 2005 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • England and Wales
